Clinical Trials in Detroit

Showing 6001-6020 of 19,719 trials

A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

NCT05032040

This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in patients with selected advanced gynecologic and genitourinary malignancies.

Ovarian CancerClear Cell CarcinomaEndometrial Cancer+2 more

Xencor, Inc.170 participantsStarted Jul 2022

Prescott, Arizona, United States • La Jolla, California, United States • Los Angeles, California, United States +14 more locations

COMPLETEDNA< 1 mile

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

NCT05971381

To evaluate repigmentation and quality of life after treatment of stable vitiligo lesions using the RECELL Device.

Vitiligo

Avita Medical109 participantsStarted Aug 2023

Scottsdale, Arizona, United States • Irvine, California, United States • San Diego, California, United States +14 more locations

A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Find Trials by Condition in Detroit

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer

A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Framing Eighteen Coils in Cerebral Aneurysms Trial

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors

Open-Label Study of Setmelanotide in Hypothalamic Obesity

Comparative Effectiveness of Operative Versus Non-Operative Treatments for Rotator Cuff Tears

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children

Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors